Emory University as of March 31, 2015
Portfolio Holdings for Emory University
Emory University holds 10 positions in its portfolio as reported in the March 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO) | 81.8 | $43M | 1.1M | 40.87 | |
| Anacor Pharmaceuticals In | 2.6 | $1.3M | 23k | 57.83 | |
| BioMarin Pharmaceutical (BMRN) | 2.3 | $1.2M | 9.7k | 124.65 | |
| Incyte Corporation (INCY) | 2.2 | $1.2M | 13k | 91.68 | |
| Bellicum Pharma | 2.0 | $1.0M | 45k | 23.18 | |
| Seattle Genetics | 2.0 | $1.0M | 30k | 35.35 | |
| Genomic Health | 1.9 | $983k | 32k | 30.56 | |
| Synageva Biopharma | 1.8 | $961k | 9.9k | 97.52 | |
| ACADIA Pharmaceuticals (ACAD) | 1.8 | $957k | 29k | 32.60 | |
| BioCryst Pharmaceuticals (BCRX) | 1.7 | $886k | 98k | 9.03 |
